Phase 4 Bipolar Disorder Trial, Recruiting NCT04057378 Sponsor: Region Örebro County Condition: Bipolar Disorder
Back to Bipolar Disorder

Phase 4 Bipolar Disorder Trial, Recruiting

NCT04057378
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old at the time of joining the trial
  • People who have been diagnosed with a depressive episode, either unipolar depression or bipolar depression, according to standard diagnostic guidelines (ICD-10)
  • People for whom electroconvulsive therapy (ECT) — a medical treatment involving brief electrical stimulation of the brain — has been recommended and who have agreed to receive it
  • People who have a Swedish personal identity number
  • People who are able to understand and agree to take part in the trial on their own behalf

Who may not be able to join:

  • People for whom the treating doctor considers a particular pulse width setting (a technical aspect of the ECT treatment) to be unsuitable for that individual (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Axel Nordenskjöld, Örebro University, Region Örebro län

Phone: +46196021000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Region Örebro County
Registry
ClinicalTrials.gov
Start date
30 October 2019
Est. completion
15 November 2025

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Remission

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov